参考文献/References:
[1] ROMAN B R, AWAD M, PATEL S G. De.ning value-driven care in head and neck oncology[J]. Current Oncology Reports, 2015, 17(1): 424.
[2] DI DONNA V, SANTORO M G, DE WAURE C, et al. A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease[J]. Thyroid, 2014, 24(12): 1759-1764.
[3] 贺青卿，董学峰，于芳．甲状腺乳头状癌淋巴结转移的特点及临床处理策略 [J]．中华内分泌外科杂志， 2015, 9(1): 1-3. HE Qingqing,DONG Xuefeng,YU Fang.The characteristics of lymph node metastasis in papillary thyroid carcinoma and its clinical management[J]. Chinese Journal of Endocrine Surgery,2015,9(1):1-3.
[4] 张瑾，段肖飞．促甲状腺激素检测在甲状腺乳头状癌诊断中的应用价值 [J]．上海医药，2019，40（15）： 45-47． ZHANG Jin,DUAN Xiaofei. The application value of thyroid stimulating hormone in the diagnosis of papil-lary thyroid carcinoma [J].Shanghai Medical&Pharma-ceutical Journal,2019,40(15): 45-47.
[5] 郝少龙 , 马纪红 , 刘新承 , 等 .外周血 TSHR-mRNA检测在甲状腺乳头状癌中的临床意义 [J].中华普外科手术学杂志 (电子版 )，2017,11(16):491-495. HAO Shaolong,MA Jihong,LIU Xincheng,et al. The clinical signi.cance of peripheral blood TSHR-mRNA detection in papillary thyroid carcinoma [J].Clin J Oper Proc Gen Surg,2017,11(16):491-495.
[6] 彭亮，解敬慧，张延军．促甲状腺激素受体对分化型甲状腺癌 131I治疗效果预测价值 [J]．临床军医杂志 , 2016,44(1):49-52. PENG Liang,XIE Jinghui,ZHANG Yanjun,et al. Predictive value of thyrotropin receptor in radioactive iodine therapy of differentiated thyroid carcinoma [J]. Clin J Med Of.c,2016,44(1):49-52.
[7] FüHRER D, BRIX K, BIEBERMANN H. Understanding the healthy thyroid state in 2015[J]. European Thyroid Journal, 2015, 4(Suppl 1): 1-8.
[8] 卢燕红 , 王圣应 .甲状腺乳头状癌罕见的侵袭性变异型 [J].中华内分泌外科杂志 ,2014,8(1):71-73. LU Yanhong,WANG Shengying.Rare invasive variant of papillary thyroid carcinoma[J].Chinese Journal of Endocrine Surgery,2014,8(1):71-73.
[9] D’AGOSTINO M, SPONZIELLO M, PUPPIN C A, et al. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics[J]. Journal of Molecular Endocrinology, 2014, 52(2): 121-131.
相似文献/References:
[1]李桂荣,赵清侠a,宋 斌b,等.miR-221与miR-222在甲状腺乳头状癌组织中的表达及临床意义[J].现代检验医学杂志,2017,32(01):41.[doi:10.3969/j.issn.1671-7414.2017.01.012]
LI Gui-rong,ZHAO Qing-xiaa,SONG Binb,et al.Expression of miR-221 and miR-222
in Papillary Thyroid Carcinoma Tissues and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(01):41.[doi:10.3969/j.issn.1671-7414.2017.01.012]
[2]孟凡萍,郝 坡,范 慧.甲状腺乳头状癌并发桥本氏甲状腺炎患者BRAF-V600E 基因表达及T 淋巴细胞亚群分析[J].现代检验医学杂志,2020,35(01):32.[doi:10.3969/j.issn.1671-7414.2020.01.009]
MENG Fan-ping,HAO Po,FAN Hui.Expression of BRAF-V600E Gene and Analysis of Lymphocyte Subgroup in
Thyroid Papillary Carcinoma Combined with Hashimoto's Thyroiditis[J].Journal of Modern Laboratory Medicine,2020,35(01):32.[doi:10.3969/j.issn.1671-7414.2020.01.009]
[3]宋晓龙,宋 宇,魏 龙,等.血清TK1，TSH，TG，TGAb 检测联合TI RADS 分类在甲状腺乳头状癌早期筛查中的应用价值[J].现代检验医学杂志,2022,37(04):38.[doi:10.3969/j.issn.1671-7414.2022.04.008]
SONG Xiao-long,SONG Yu,WEI Long,et al.Clinical Value of Serum TK1, TSH, TG and TGAb Detection Combined with TI-RADS Classification in Papillary Thyroid Carcinoma[J].Journal of Modern Laboratory Medicine,2022,37(01):38.[doi:10.3969/j.issn.1671-7414.2022.04.008]
[4]宋晓龙,魏 龙,秦晋铝,等.甲状腺乳头状癌患者术前血清TK1 表达水平联合甲状腺超声特征构建中央区淋巴结转移预测模型及验证[J].现代检验医学杂志,2023,38(01):1.[doi:10.3969/j.issn.1671-7414.2023.01.001]
SONG Xiao-long,WEI Long,QIN Jin-lü,et al.Construction and Validation of Prediction Model of Central Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma Based on Preoperative Serum TK1 Expression Level and Thyroid Ultrasound Features[J].Journal of Modern Laboratory Medicine,2023,38(01):1.[doi:10.3969/j.issn.1671-7414.2023.01.001]
[5]刘 星,霍占江.甲状腺乳头状癌组织中galecti-3 与miR-375 水平表达意义及相关性研究[J].现代检验医学杂志,2023,38(01):49.[doi:10.3969/j.issn.1671-7414.2023.01.010]
LIU Xing,HUO Zhan-jiang.Expression Significance and Correlation of galectin-3 and miR-375 in Papillary Thyroid Carcinoma Tissue[J].Journal of Modern Laboratory Medicine,2023,38(01):49.[doi:10.3969/j.issn.1671-7414.2023.01.010]
[6]那将超,狄长安.甲状腺乳头状癌患者术后血清MMIF 和IL-6 表达水平与甲状旁腺功能减退持续时间的相关性研究[J].现代检验医学杂志,2023,38(01):191.[doi:10.3969/j.issn.1671-7414.2023.01.036]
NA Jiang-chao,DI Chang-an.Correlation between Postoperative Serum MMIF and IL-6 Expression Levels and Duration of Hypoparathyroidism in Patients with Papillary Thyroid Cancer[J].Journal of Modern Laboratory Medicine,2023,38(01):191.[doi:10.3969/j.issn.1671-7414.2023.01.036]
[7]薛思军a,涂霁韬b.甲状腺乳头状癌组织中miR-137 水平表达及相关实验研究[J].现代检验医学杂志,2023,38(04):121.[doi:10.3969/j.issn.1671-7414.2023.04.022]
XUE Sijuna,TU Jitaob.Expression of miR-137 in Papillary Thyroid Carcinoma Tissue and Its Related Experimental Study[J].Journal of Modern Laboratory Medicine,2023,38(01):121.[doi:10.3969/j.issn.1671-7414.2023.04.022]
[8]周 钧a,汪庭军b,唐 珍a.甲状腺乳头状癌患者血清EGR1/2 mRNA 水平检测在临床早期实验诊断中的价值研究[J].现代检验医学杂志,2023,38(05):93.[doi:10.3969/j.issn.1671-7414.2023.05.018]
ZHOU Juna,WANG Tingjunb,TANG Zhena.Value of Serum EGR1/2 mRNA Detection in Early Clinical Diagnosis of Papillary Thyroid Carcinoma[J].Journal of Modern Laboratory Medicine,2023,38(01):93.[doi:10.3969/j.issn.1671-7414.2023.05.018]